אופב 100 מג ישראל - עברית - Ministry of Health

אופב 100 מג

boehringer ingelheim israel ltd. - nintedanib as esilate - קפסולות רכות - nintedanib as esilate 100 mg

אופב 150 מג ישראל - עברית - Ministry of Health

אופב 150 מג

boehringer ingelheim israel ltd. - nintedanib as esilate - קפסולות רכות - nintedanib as esilate 150 mg

לשקוטאן משחה ישראל - עברית - Ministry of Health

לשקוטאן משחה

teva israel ltd - methylbenzethonium chloride; paromomycin as sulfate - משחה - methylbenzethonium chloride 12 %w/w; paromomycin as sulfate 15 %w/w - paromomycin - paromomycin - topical treatment of cutaneous leishmaniasis.

ג'נואט 50 מג500 מג ישראל - עברית - Ministry of Health

ג'נואט 50 מג500 מג

merck sharp & dohme (israel - 1996) company ltd, israel - metformin hydrochloride; sitagliptin as monohydrate phosphate - טבליה - sitagliptin as monohydrate phosphate 50 mg; metformin hydrochloride 500 mg - metformin - metformin - januet is indicated as an adjunct to diet and exercise to improve glycemic control in adult patients with type 2 diabetes mellitus. important limitations of use:januet should not be used in patients with type 1 diabetes or for the treatment of diabetic ketoacidosis, as it would not be effective in these settings.januet has not been studied in patients with a history of pancreatitis. it is unknown whether patients with a history of pancreatitis are at increased risk for the development of pancreatitis while using januet.

ג'נואט 50 מג850 מג ישראל - עברית - Ministry of Health

ג'נואט 50 מג850 מג

merck sharp & dohme (israel - 1996) company ltd, israel - metformin hydrochloride; sitagliptin as monohydrate phosphate - טבליה - sitagliptin as monohydrate phosphate 50 mg; metformin hydrochloride 850 mg - metformin - metformin - januet is indicated as an adjunct to diet and exercise to improve glycemic control in adult patients with type 2 diabetes mellitus. important limitations of use:januet should not be used in patients with type 1 diabetes or for the treatment of diabetic ketoacidosis, as it would not be effective in these settings.januet has not been studied in patients with a history of pancreatitis. it is unknown whether patients with a history of pancreatitis are at increased risk for the development of pancreatitis while using januet.

טרג'נטה דואו 2.5 מג500 מג ישראל - עברית - Ministry of Health

טרג'נטה דואו 2.5 מג500 מג

boehringer ingelheim israel ltd. - linagliptin; metformin hydrochloride - טבליות מצופות פילם - metformin hydrochloride 500 mg; linagliptin 2.5 mg - metformin - metformin - as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus when treatment with both linagliptin and metformin is appropriate.

טרג'נטה דואו 2.5 מג850  מג ישראל - עברית - Ministry of Health

טרג'נטה דואו 2.5 מג850 מג

boehringer ingelheim israel ltd. - linagliptin; metformin hydrochloride - טבליות מצופות פילם - metformin hydrochloride 850 mg; linagliptin 2.5 mg - metformin - metformin - as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus when treatment with both linagliptin and metformin is appropriate.

טרג'נטה דואו 2.5 מג1000 מג ישראל - עברית - Ministry of Health

טרג'נטה דואו 2.5 מג1000 מג

boehringer ingelheim israel ltd. - linagliptin; metformin hydrochloride - טבליות מצופות פילם - linagliptin 2.5 mg; metformin hydrochloride 1000 mg - metformin - metformin - as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus when treatment with both linagliptin and metformin is appropriate.

טרג'נטה ישראל - עברית - Ministry of Health

טרג'נטה

boehringer ingelheim israel ltd. - linagliptin - טבליות מצופות פילם - linagliptin 5 mg - linagliptin - linagliptin - as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus

פרדקסה 75 ישראל - עברית - Ministry of Health

פרדקסה 75

boehringer ingelheim israel ltd. - dabigatran etexilate as mesilate - קפסולות - dabigatran etexilate as mesilate 75 mg - dabigatran etexilate - dabigatran etexilate - primary prevention of venous thromboembolic events in adult patients who have undergone elective total hip replacement surgery or total knee replacement surgery.